Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 2
1946 2
1947 2
1948 1
1953 1
1968 1
1970 1
1972 1
1978 3
1979 1
1980 4
1981 4
1982 1
1983 3
1984 3
1985 5
1986 2
1987 7
1988 13
1989 9
1990 8
1991 5
1992 12
1993 5
1994 5
1995 7
1997 2
1999 3
2001 1
2002 6
2003 2
2004 2
2005 7
2006 8
2007 5
2008 6
2009 7
2010 7
2011 7
2012 4
2013 7
2014 5
2015 5
2016 10
2017 12
2018 2
2019 4
2020 3
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
Channeling pain through GPCRs.
Gough NR. Gough NR. Science. 2017 Jan 13;355(6321):143-144. doi: 10.1126/science.355.6321.143-h. Science. 2017. PMID: 28082564 No abstract available.
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Computational biology.
Ray LB, Chong LD, Gough NR. Ray LB, et al. Among authors: gough nr. Sci STKE. 2002 Sep 3;2002(148):eg10. doi: 10.1126/stke.2002.148.eg10. Sci STKE. 2002. PMID: 12209051 No abstract available.
Focus issue: conquering the data mountain.
Gough NR, Yaffe MB. Gough NR, et al. Sci Signal. 2011 Feb 15;4(160):eg2. doi: 10.1126/scisignal.2001871. Sci Signal. 2011. PMID: 21325201
Beyond canonical: The Wnt and β-catenin story.
Moon RT, Gough NR. Moon RT, et al. Among authors: gough nr. Sci Signal. 2016 Apr 5;9(422):eg5. doi: 10.1126/scisignal.aaf6192. Sci Signal. 2016. PMID: 27048563
2013: Signaling breakthroughs of the year.
Berndt JD, Gough NR. Berndt JD, et al. Among authors: gough nr. Sci Signal. 2014 Jan 7;7(307):eg1. doi: 10.1126/scisignal.2005013. Sci Signal. 2014. PMID: 24399293
Teaching with STKE.
Gough NR. Gough NR. Sci STKE. 2005 Feb 1;2005(269):eg3. doi: 10.1126/stke.2692005eg3. Sci STKE. 2005. PMID: 15687507
222 results